Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
NCT06354439

Use of Letrozole for Ectopic Pregnancy

Led by Hospital de Clinicas de Porto Alegre · Updated on 2024-04-09

130

Participants Needed

1

Research Sites

144 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A randomized clinical trial using oral letrozole 10mg/day for 7 days, for treating early cases of ectopic pregnancy, compared to intramuscular methotrexate

CONDITIONS

Official Title

Use of Letrozole for Ectopic Pregnancy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Diagnosis of ectopic pregnancy
  • Desire for reproduction
  • Ease of return
  • Undetermined pregnancy location with abnormal hCG growth
  • Presence of a heterogeneous adnexal mass on pelvic ultrasound suggestive of a tubal ectopic pregnancy with an hCG level 64 3000 mIU/ml
  • Absence of fetal cardiac activity
  • Average diameter of the adnexal mass 64 3.5 cm
  • Hemodynamically stable
  • No significant abdominal pain (i.e, < 6 on a visual analog scale)
Not Eligible

You will not qualify if you...

  • Presence of a significant amount of free fluid in the pelvis (as assessed by the ultrasound technician)
  • Allergy to methotrexate or letrozole
  • A reduction in b2-hCG 65 50% in 2 measurements with 48 hours between them or

65 85% in 4 days, or 65 95% in 7 days before randomization

  • Abnormal liver function test (Alanine transaminase (ALT) 65 2 times the upper limit of normal)
  • Abnormal renal function test (glomerular filtration rate 64 45 ml/min)
  • Hemoglobin <10 g/dl
  • Platelets <120.000/ml
  • Presence of heterotopic pregnancy
  • Do not wish to participate in the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil, 90035-903

Actively Recruiting

Loading map...

Research Team

R

Ricardo F Savaris, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here